UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (date of earliest event reported):
March 17, 2010
Finisar Corporation
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation)
|
|
000-27999
(Commission File No.)
|
|
94-3038428
(I.R.S. Employer Identification
No.) |
1389 Moffett Park Drive
Sunnyvale, CA 94089
(Address of principal executive offices)
Registrant’s telephone number, including area code:
(408) 548-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 1.01 Entry into a Material Definitive Agreement
On March 17, 2010, Finisar Corporation, a Delaware corporation (“Finisar”), and certain
directors and officers of Finisar (collectively, the “Selling Stockholders”), entered into an
Underwriting Agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. Incorporated, and
Jefferies & Co. Inc., joint book-running managers, as representatives of the several underwriters
named in the Underwriting Agreement (collectively, the “Underwriters”), pursuant to which Finisar
will sell to the Underwriters an aggregate of 8,640,000 shares of its common stock, par value
$0.001 per share, which will be sold at a price to the public of $14.00 per share, for total gross
proceeds of $121.0 million. Finisar has also granted the underwriters a 30-day option to purchase
up to an additional 1,147,093 shares of Common Stock, and the Selling Stockholders have granted the
underwriters an option to purchase up to an additional 148,907 shares, solely to cover
over-allotments, if any. Finisar will not receive any proceeds from any sale of shares by the
Selling Stockholders.
The shares are being sold pursuant to Finisar’s registration statement on Form S-3 filed with
the U.S. Securities and Exchange Commission (the “SEC”) on March 15, 2010 (Registration
No. 333-165479).
A copy of the Underwriting Agreement is attached hereto as Exhibit 1.1, and the foregoing
description is qualified in its entirety by reference to the Underwriting Agreement.
A copy of the press release announcing the pricing of the shares to be sold in the offering is
attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
1.1
|
|
Underwriting Agreement, dated March 17, 2010, by and among
Finisar Corporation, the selling stockholders named in
Schedule I thereto, and Morgan Stanley & Co. Incorporated and
Jefferies & Co. Inc., as representatives of the several
underwriters named in Schedule II thereto |
|
|
|
99.1
|
|
Press Release of Finisar Corporation dated March 17, 2010 |
2